MSP Recovery (FRA:CN50) Research & Development: €0.00 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CN50 MSP Recovery Inc FRA:CN50
28 GF Score
Price €10.59
GF Value €777,122.50
! 5 Warning Signs
View Full Analysis

What is MSP Recovery Research & Development?

MSP Recovery FRA:CN50 28 Research & Development is €0.00 Mil as of Sep. 2025. GuruFocus rates FRA:CN50 with a GF Score™ of 28/100 and a GF Value™ of €777,122.50. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. MSP Recovery's Research & Development for the three months ended in Sep. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was €0.00 Mil.

MSP Recovery  (FRA:CN50) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

MSP Recovery Research & Development Related Terms

MSP Recovery Research & Development Historical Data

* Premium members only.

The historical data trend for MSP Recovery's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MSP Recovery Research & Development Chart

MSP Recovery Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
0.00 0.00 0.00 0.00 0.00

MSP Recovery Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:CN50
28GF Score
MSP Recovery Inc FRA:CN50
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MSP Recovery Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
MSP Recovery (FRA:CN50) has a Research & Development of €0.00 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on MSP Recovery and its competitors.
Is MSP Recovery's Research & Development too high?
MSP Recovery's current Research & Development is €0.00 Mil. Overall, MSP Recovery has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does MSP Recovery's Research & Development compare to BACK and VEEV?
MSP Recovery's Research & Development of €0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on MSP Recovery and its competitors. MSP Recovery's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MSP Recovery stock overvalued right now?
MSP Recovery (FRA:CN50) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €777,122.50, compared to a current price of €10.59 — trading 100% below its estimated fair value. The current Research & Development is €0.00 Mil. MSP Recovery's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For MSP Recovery (FRA:CN50), the current Research & Development is €0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MSP Recovery (FRA:CN50) Overvalued in 2026?

Based on GuruFocus' analysis, MSP Recovery stock appears to be undervalued. The current stock price of €10.59 is trading 100% below its estimated GF Value™ of €777,122.50.

Key valuation signals for FRA:CN50:

  • Research & Development: €0.00 Mil
  • GF Value™: €777,122.50 vs. price of €10.59 (100% below fair value)
  • GF Score™: 28/100 with 5 warning signs

No single metric tells the full story. See the FRA:CN50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MSP Recovery Business Description

Other Exchanges MSPR:USA
Address 3150 SW 38th Avenue, Suite 1100, Miami, FL, USA, 33146
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.
28GF Score

Get the complete analysis for FRA:CN50

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.59
Price
€777,122.50
GF Value